Peer Review History
| Original SubmissionJune 14, 2024 |
|---|
|
Dear Dr. Zan, plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, De-Chih Lee, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This work was supported by Hawaii Department of Human Services, United States of America.” Please state what role the funders took in the study. If the funders had no role, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 5. We notice that your supplementary figure are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. Additional Editor Comments: Please make a major revision based on the reviewer's comments. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Major Objections 1. The scale used is specific to Hawaii and is not sufficiently described in the article to ascertain its effectiveness in evaluating the functional status of participants. One must refer to the references to understand this scale, which appears to evaluate both functional status (several questions similar to the Katz or Lawton scales) and cognitive status (questions V and VI). The authors explain that a total score out of 38 is obtained, but it is unclear how this score is calculated from the 17 questions on the scale. This aspect is crucial as placement in nursing homes typically results from significant cognitive deterioration rather than functional decline. It would be useful to reanalyze the data using a score based solely on questions VII to XVII, which are comparable to functional status scales commonly used in the scientific literature. Additionally, the cognitive scores (questions V and VI) for the matched sample between the three groups should be described. The goal is to understand whether the accelerated decline observed in nursing homes is due to cognitive or functional deterioration of the participants. 2. The exclusion of participants who changed residences is a major bias; at the very least, the number of such individuals should be described for the "home" group. If only participants who did not die during follow-up and did not change residences are compared, and there is no adjustment for cognitive status, it is unsurprising that the total score trajectory is unfavorable for nursing homes. A competitive risk model including mortality could have been used for this study. All these aspects greatly limit the interpretation of the results, despite efforts made using the propensity score. Minor Objections 3. The Hawaiian foster home model proposed should be better described in terms of criteria for admission, medical and paramedical supervision, and social interactions. Is this model intended for frail individuals, and if so, based on what criteria? 4. Abstract: The summary should be revised to specify the sample sizes, methods, and main quantified results. A single concluding sentence is sufficient. 5. Introduction: There are several contradictory passages, for example regarding mortality: “Studies comparing residents living in assisted living versus nursing homes also did not find a significant difference in physical function, cognition, mental health, or mortality outcomes between the two settings over time.” And immediately after: “For example, nursing home residents tend to have higher risk of mortality, significant comorbidities and more complex needs, lower functional status, and use more intensive health care services compared to individuals living in HCB settings.” 6. The paragraph on the “Conceptual Framework” is not very useful and could be summarized in two or three sentences. 7. The hyperlink “Form 1147” does not work. 8. The title of Table 2 should be more explanatory. 9. Discussion: I do not understand the sentence: “This observation aligns with findings from previous studies. For example, an Oregon study identified high substitutability of adult foster care for nursing home care. That is, with every additional foster home resident in a county, a nursing home in that county loses a resident.” 10. The limits of the study should be included in the discussion section mais should be developed (see major comments). Reviewer #2: This study compares functional decline over time in 3 settings: home, foster homes and nursing home. This article provides relevant information to the readers. I praise the authors for their research. While authors highlight differences in age, race, marital status and setting of care, I believe authors could highlight the differences in comorbidities, cognitive impairment between the individuals selected in each setting. It is only intuitive to think that individual are admitted to the nursing home with higher level of medical complexity, comorbidities or cognitive decline that make them require more assistance in ADLs. I would like to see how these characteristics pan out as comparisons between each group, as they may determine the degree of decline that is being identified. The degree of decline might be associated with comorbidities and medical conditions rather than actual settings alone. I feel that comparisons of degree of decline will be stronger if these are incorporated into the analysis. In the discussion there is mention of 'better health' among individuals who receive care at home. Could you expand on what specifically are you referring to by 'better health'? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Denis Boucaud-Maitre Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Zan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, M. Mahmud Khan Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: The article has been substantially revised, incorporating differentiated analyses on cognition and functional status. The main finding is that residents in foster homes exhibited a greater functional decline compared to those residing in private homes. I maintain that the conclusions and interpretations of the results should be approached with greater nuance, particularly regarding the statement: “These findings suggest that, when possible, Medicaid agencies should prioritize supporting long-term care in private homes.” Placement in nursing homes or foster homes occurs when remaining at home is either undesirable or unfeasible. Comorbidities such as diabetes, renal insufficiency, stroke history, hemiplegia, cancer, etc., which may explain placement in nursing or foster homes, were not accounted for. While a decline in functional status is indeed observed, other parameters are equally important, including mortality, hospitalizations, quality of life, social isolation etc. These factors play a critical role in guiding policymakers and families in choosing among various housing options. It is therefore, in my opinion, inappropriate to contrast these alternatives based solely on functional status. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: BOUCAUD-MAITRE ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
PLOS ONE Dear Dr. Zan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Overall, the clarity of certain sections of the manuscript, particularly the Methods section, require improvement to enhance readers' understanding of the analyses performed and to ensure reproducibility. For instance, the following statement lacks clarity: “Individuals at home were matched to those living in foster homes and nursing homes respectively, and then the two separate matched samples were merged by individuals in the home setting." Specifically, the meaning of “merged by individuals in the home setting” is unclear and needs further explanation. It is also pertinent to explicitly include the regression equations used for the analysis to provide transparency and facilitate reproducibility. Furthermore, illustrating the estimated slopes using figures would significantly improve the presentation and understanding of results. For reference, the figures presented in the article titled “Poor hemorrhagic stroke outcomes during the COVID-19 pandemic are driven by socioeconomic disparities: analysis of nationally representative data” (BMJ Neurology Open) offer a good example of how to visualize equations involving change in slope. Additionally, clarification is required for the following statement: “In addition, since the assessment form covers various aspects of LOC needs—such as ADL, which are comparable to functional status scales in the literature, and cognition—5 we further compared the average scores for each assessment item by setting after matching and analyzed the change in LOC scores for ADL (Items VII-XIII in Form 1147) and cognition (Items V-VI) separately by setting.” The phrasing is presently ambiguous, particularly regarding the comparison and analysis of LOC scores. A more precise description would greatly enhance the reader’s comprehension. While the manuscript attempts to justify why race and LOC remained statistically significant despite matching, such results often point to imperfect matching and residual confounding, which could bias the conclusions. To address this, I strongly recommend evaluating and reporting balance metrics for the propensity score model, utilizing tools such as standardized mean differences or visual plots to assess covariate balance. Additionally, exploring alternative methods, including propensity score stratification or inverse probability weighting (IPW), may help to address the issue of imperfect balance and improve the robustness of the findings. Finally, it is concerning that the authors evaluated the Medicaid population aged 65 and older without addressing the issue of dual eligibles or discussing how their dual status might influence the results. It is equally important to provide context on how these older adults came to be Medicaid recipients. Such omissions leave critical gaps in the interpretation of the findings and the broader implications of the study. I strongly recommend that the authors include a discussion of dual eligibility and its potential impact, as well as a clear explanation of the circumstances leading to older adults being enrolled in Medicaid. Please submit your revised manuscript by May 14 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Abdulaziz T. Bako, MBBS; MPH; PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Dear authors, thank you for taking into account my latest comments, which help to qualify your results, and congratulations on your article. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Boucaud-Maitre ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
Home settings are associated with less functional decline among older adults compared to community-care foster homes and skilled nursing facilities in Hawaii PONE-D-24-22552R3 Dear Dr. Zan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Abdulaziz T. Bako, MBBS; MPH; PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-22552R3 PLOS ONE Dear Dr. Zan, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Abdulaziz T. Bako Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .